CVS Caremark Expands Biosimilar Adoption Through Formulary Updates to Improve Affordability and Access
Go back to CVS Caremark Expands Biosimilar Adoption Through Formulary Updates to Improve Affordability and Access| CVS Caremark Corp. (NYSE: CVS) | Delayed: 101.57 +0.27 (0.27%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $101.30 | 52 Week High | $106.67 | |||
| Open | $101.56 | 52 Week Low | $69.30 | |||
| Day High | $102.05 | P/E | 27.09 | |||
| Day Low | $100.79 | EPS | $3.75 | |||
| Volume | 5,964,669 | |||||
